Following the European Commission’s draft proposal for implementing the so-called SPC manufacturing waiver the Committee on Legal Affairs of the European Parliament published a draft report on presenting its suggested...more
1/15/2019
/ EU ,
European Commission ,
European Parliament ,
Generic Drugs ,
Intellectual Property Protection ,
Life Sciences ,
Manufacturers ,
Marketing Perspectives ,
Patent Expiration ,
Patent Infringement ,
Patents ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Supplementary Protection Certificate ,
Waivers